Inhaled Nitric Oxide Therapy Alx1 Well Tolerated in Ph1 Trial
Phase 1 data for the investigational inhaled nitric oxide therapy Alx1 demonstrated the treatment was well tolerated with no serious side effects in healthy volunteers.
Tag: inhaled nitric oxide
All
Latest
Inhaled Nitric Oxide Therapy Alx1 Well Tolerated in Ph1 Trial
Phase 1 data for the investigational inhaled nitric oxide therapy Alx1 demonstrated the treatment was well tolerated with no serious side effects in healthy volunteers.
Read More
Phase 1 Data Incoming for ALX1 iNO Therapy
Phase 1 results for the inhaled drug candidate ALX1 focus on safety and pharmacokinetics for the treatment of serious lung diseases.
Read More
Airgas Therapeutics Ulspira iNO Therapy
The Ulspira Solution combines inhaled nitric oxide (iNO) gas with a portable delivery system and clinical support to treat infants with hypoxic respiratory failure.
Read More
Additional Correction for NOxBOXi Due to Dosing Fluctuations
Customers reported fluctuations in the monitored nitric oxide value (over ±20% of the set dose) when the NOxBOXi system is used with specific settings on the Bunnell LifePulse ventilator.
Read More
Correction Issued for NOxBOXi Nitric Oxide System Due to Button Pushing
A correction was issued to alert users not to rapidly push buttons when operating the NOxBOXi Nitric Oxide Delivery System.
Read More
RT 2025 Product Focus: The Digital Edition
RT’s 2025 Product Focus provides a detailed look at 68 of the newest medical devices, including 33 exclusive products not available in the print edition.
Read More
Products 2025: Gas Delivery & Humidification
The latest devices in humidification, oxygen therapy and inhaled nitric oxide delivery from Beyond Air, Caire, Flexicare, Hans Rudolph Inc, Linde Gas & Equipment, Maxtec, Neotech Products, and Vero Biotech.
Read More
Beyond Air Granted US Patent Covering Treatment of NTM Infections Using Gaseous Nitric Oxide
Beyond Air received a US Patent for its method of delivering gaseous nitric oxide (gNO) to a patient that has a condition associated with non-tuberculous mycobacteria (NTM) lung infection.
Read More
Innovations in Inhaled Nitric Oxide Delivery
In this edition of our “Industry Analysis” series, RT magazine speaks with manufacturers of inhaled nitric oxide delivery systems about the latest market innovations in the iNO industry.
Read More
Linde Submits NOxBox I Plus for FDA Clearance
Linde Gas & Equipment Inc has submitted a 510(k) premarket notification to the FDA for its NOxBox I Plus, a nitric oxide delivery and monitoring system.
Read More
LungFit PH Receives Market Authorization in Australia
Beyond Air’s LungFit PH has received market authorization from the Australian Therapeutic...
Read More
Wisconsin Hospital Becomes First to Implement New Nitric Oxide Delivery System
The hospital is using the INOmax Evolve DS system, a nitric oxide delivery device used with mechanical ventilation for critically ill patients.
Read More
Mallinckrodt Expands Rollout of INOmax Evolve DS
Mallinckrodt has begun a national rollout of the INOmax Evolve DS delivery system, which is FDA-cleared to provide inhaled nitric oxide to certain neonatal ICU patients in order to improve oxygenation and reduce the need for extracorporeal membrane oxygenation.
Read More
Unmasking Undiagnosed Asthma and COPD Improves Health
Identifying and treating people with previously undiagnosed asthma or COPD led to improved respiratory symptoms, quality of life, and reduced healthcare visits in the year after diagnosis.
Read More
High-dose Inhaled Nitric Oxide Decreased ARDS-related Mortality Risk in Black Patients with COVID-19
High-dose inhaled nitric oxide (iNO) therapy may improve oxygenation and reduce the risk of ARDS-related mortality among critically ill Black patients with COVID-19, according to a first-of-its-kind study published in the American Journal of Respiratory and Critical Care Medicine.
Read More
FDA Clears INOmax Evolve DS
The INOmax Evolve DS is Mallinckrodt’s next-generation nitric oxide delivery system that includes a primary delivery system, a monitoring system, an electronic blender, automated backup delivery, mini-cylinders, and more.
Read More
High-dose Inhaled Nitric Oxide Aids COVID-19 Respiratory Failure
A phase 2 study showed the treatment improved blood oxygen levels and lowered the risk of long-term sensory and motor neurologic symptoms.
Read More
Mallinckrodt Recalls One-Way Valve Due to Ventilation Interruption Risk
Mallinckrodt Manufacturing is recalling its one-way valve, 22F x 22M, due to devices not opening properly, which prevents or reduces the flow of ventilated air or oxygen.
Read More
NOxBOXi Nitric Oxide Systems Recalled
The recall was issued due to a misalignment of the check valve in the device’s manifold, which may cause the manifold to fail and interrupt therapy to neonates.
Read More
RT 2023 Product Focus: The Digital Edition
RT’s 2023 Product Focus provides a detailed look at 42 of the newest medical devices, including 18 exclusive products not available in the print edition.
Read More
Market Analysis: The Impact of Cylinder-free Systems on Inhaled Nitric Oxide Delivery
RT magazine spoke with manufacturers of inhaled nitric oxide delivery systems about the latest market innovations in the iNO industry, specifically about the impact of cylinder-free (“tankless”) systems, plus research on its potential use to treat other cardiopulmonary diseases.
Read More
RT 2023 January-February: The Digital Edition
In RT’s January-February 2023 issue, RTs offer 5 tips for measuring spirometry and 8 considerations for delivering oxygen therapy to COPD patients; airway clearance options for bronchiectasis; and cylinder-free solutions for nitric oxide delivery.
Read More
3rd Generation Tankless Inhaled Nitric Oxide System Gets FDA Approval
The US FDA has approved the third Generation Genosyl Delivery System, a tankless inhaled nitric oxide (iNO) therapy device, according to manufacturer Vero Biotech Inc.
Read More
RT 2022 October-November: The Digital Edition
In RT’s October-November 2022 issue, we cover proper tracheostomy care techniques; endotracheal suctioning in the NICU/PICU; accurate interpretation of arterial blood gases; and inhaled nitric oxide delivery.
Read More